Potentiation of Coronary Vasoconstriction by Beta–adrenergic Blockade in Patients with Coronary Artery Disease

Although,β-adrenergic blocking agents reduce myocardial oxygen consumption and symptoms of myocardial ischemia in patients with coronary artery disease (CAD), propranolol has been reported to exacerbate coronary artery spasm in some patients with variant angina. To determine whether increased coronary vasomotor tone can be induced by β-adrenergic blockade, we measured the changes in coronary vascular resistance (CVR) during cold pressor testing (CPT) in 15 patients, nine with severe CAD and six with normal left coronary anatomy, before and after i.v. propranolol (0.1 mg/kg). Coronary blood flow was measured by coronary sinus thermodilution. CVR was calculated as mean arterial pressure divided by coronary sinus blood flow. Heart rate was maintained constant at a paced subanginal rate of 95 ± 5 beats/min.Before propranolol, CPT induced significant increases in coronary vascular resistance in patients with CAD (15.0 ± 2.2%, p < 0.02), but no increase in CVR in the normal patients. After propranolol, the CVR change during CPT was augmented for patients with CAD (29 ± 6%, p < 0.01) and for the normal population (9 ± 5%, NS). The potentiated increase in CVR occurred without significant changes in resting CVR or in the magnitude of the hypertensive response to CPT.We conclude that,β-adrenergic blockade with propranolol can potentiate coronary artery vasoconstriction in some patients with CAD, possibly mediated by unopposed α-adrenergic vasomotor tone. These changes may be important in patients in whom intense adrenergic stimulation may increase coronary artery tone and adversely influence the balance between myocardial oxygen supply and demand.

[1]  M. Winniford,et al.  Alpha–adrenergic Blockade for Variant Angina: A Long–term, Double–blind, Randomized Trial , 1983, Circulation.

[2]  G. Baroldi Pathophysiology of acute myocardial infarction. , 1983, Upsala journal of medical sciences.

[3]  W. Vaughn,et al.  Exacerbation of Vasotonic Angina Pectoris by Propranolol , 1982, Circulation.

[4]  C. Conti,et al.  Regional coronary angiographic observations during cold stimulation in patient with exertional chest pain: comparison of diameter responses in normal and fixed stenotic vessels. , 1981, American heart journal.

[5]  R. Miller,et al.  Provocation of Coronary Artery Spasm by the Cold Pressor Test: Hemodynamic, Arteriographic and Quantitative Angiographic Observations , 1980, Circulation.

[6]  H. Yasue,et al.  Exertional angina pectoris caused by coronary arterial spasm: effects of various drugs. , 1979, British journal of clinical practice. Supplement.

[7]  J. Oates,et al.  Variant angina pectoris: investigation of indexes of sympathetic nervous system function. , 1979, The American journal of cardiology.

[8]  H. Yasue,et al.  Circadian Variation of Exercise Capacity in Patients with Prinzmetal's Variant Angina: Role of Exercise‐induced Coronary Arterial Spasm , 1979, Circulation.

[9]  H. Swan,et al.  Mechanism of Rest Nocturnal Angina: Observations During Continuous Hemodynamic Electrocardiographic Monitoring , 1979, Circulation.

[10]  J. Oates,et al.  Comparative Assessment of Stimuli That Release Neuronal and Adrenomedullary Catecholamines in Man , 1979, Circulation.

[11]  G. Mudge,et al.  Comparison of Metabolic and Vasoconstrictor Stimuli on Coronary Vascular Resistance in Man , 1979, Circulation.

[12]  E. Antman,et al.  Coronary Artery Spasm , 1986 .

[13]  S. Chierchia,et al.  "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. , 1978, The American journal of cardiology.

[14]  J. Hamer,et al.  Effects of selective and non-selective beta-adrenergic blockade on coronary dynamics in man assessed by rapid atrial pacing. , 1978, British heart journal.

[15]  D. Harrison,et al.  Effects of alpha adrenergic blockade upon coronary hemodynamics. , 1978, The Journal of clinical investigation.

[16]  E. Feigl,et al.  Competition between Sympathetic Vasoconstriction and Metabolic Vasodilation in the Canine Coronary Circulation , 1978, Circulation research.

[17]  A. Berdeaux,et al.  EFFECTS OF ATENOLOL ON REGIONAL MYOCARDIAL BLOOD FLOW AND ST SEGMENT ELEVATION IN THE CANINE MYOCARDIUM , 1977, British journal of pharmacology.

[18]  P. Armstrong,et al.  Effects of propranolol on the hemodynamic, coronary sinus blood flow and myocardial metabolic response to atrial pacing. , 1977, The American journal of cardiology.

[19]  C. Pepine,et al.  Effects of propranolol on coronary hemodynamic and metabolic responses to tachycardia stress in patients with and without coronary disease. , 1977, Catheterization and cardiovascular diagnosis.

[20]  R. M. Mills,et al.  Reflex increase in coronary vascular resistance in patients with ischemic heart disease. , 1976, The New England journal of medicine.

[21]  G. Ross Adrenergic responses of the coronary vessels. , 1976, Circulation research.

[22]  H. Yasue,et al.  Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography. , 1976, American heart journal.

[23]  M. Endo,et al.  Prinzmetal's variant angina. Coronary arteriogram and left ventriculogram during angina attack induced by methacholine. , 1976, The New England journal of medicine.

[24]  A. Keats,et al.  PLASMA AND ATRIAL PROPRANOLOL AFTER PRE-OPERATIVE WITHDRAWAL , 1975, Circulation.

[25]  D. Shand,et al.  Clinical Pharmacology of Propranolol , 1975, Circulation.

[26]  E. Feigl Control of Myocardial Oxygen Tension by Sympathetic Coronary Vasoconstriction in the Dog , 1975, Circulation research.

[27]  E. Feigl,et al.  Analysis of coronary vascular beta receptors in situ. , 1975, The American journal of physiology.

[28]  H. Yasue,et al.  Role of Autonomic Nervous System in the Pathogenesis of Prinzmetal's Variant Form of Angina , 1974, Circulation.

[29]  S. Ayres,et al.  Propranolol in the Treatment of Acute Myocardial Infarction: Effect on Myocardial Oxygenation and Hemodynamics , 1974, Circulation.

[30]  C. Higgins,et al.  Effects of Norepinephrine on Coronary Circulation and Left Ventricular Dynamics in the Conscious Dog , 1974, Circulation research.

[31]  D. A. Duncan,et al.  Response of coronary circulation to cutaneous cold. , 1974, The American journal of medicine.

[32]  D. E. Potts,et al.  Coronary arterial spasm in Prinzmetal angina. Documentation by coronary arteriography. , 1973, The New England journal of medicine.

[33]  F. Abboud,et al.  Differences in direct effects of adrenergic stimuli on coronary, cutaneous, and muscular vessels. , 1972, The Journal of clinical investigation.

[34]  H. Swan,et al.  Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in Man , 1971, Circulation.

[35]  R. Gorlin,et al.  Cardiovascular Pharmacology of Propranolol in Man , 1969, Circulation.

[36]  B. Pitt,et al.  Adrenergic Receptor Activity in the Coronary Arteries of the Unanesthetized Dog , 1967, Circulation research.

[37]  E. Feigl Sympathetic Control of Coronary Circulation , 1967, Circulation research.

[38]  R. Gorlin,et al.  Propranolol and angina pectoris. , 1966, The American journal of cardiology.

[39]  J. Parratt BLOCKADE OF SYMPATHETIC β-RECEPTORS IN THE MYOCARDIAL CIRCULATION , 1965 .

[40]  J. Ross,et al.  An Intrinsic Adrenergic Vasodilator Mechanism in the Coronary Vascular Bed of the Dog , 1965, Circulation research.